人 iPSC 衍生的临床前模型用于识别具有临床潜力的肿瘤特异性 T 细胞的毒性
Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential.
47.2分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential.
Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology.
Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem Cells.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。